[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 11, Issue 2 (Int J Mol Cell Med (In Press) 2022) ::
Int J Mol Cell Med 2022, 11(2): 0-0 Back to browse issues page
Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovaries Syndrome: A Prominent COVID-19 Risk Factor
Jamshid Roozbeh1 , Sahar Janfeshan1 , Afsoon Afshari1 , Aida Doostkam1 , Ramin Yaghobi 2
1- Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
2- Shiraz Transplant Research Center, Shiraz University of Medical Sciences-Shiraz, Iran. , rayaviro@yahoo.com
Abstract:   (195 Views)
Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infecting mechanism depends on hosting angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) as essential components and androgens as regulators for inducing the expression of these components. Therefore, hyperandrogenism-related disease such as polycystic ovary syndrome (PCOS) in insulin resistant women in reproductive-age is a high-risk factor for SARS-CoV-2 infection. Here, we describe the signaling pathways that might increase the susceptibility and severity of this new pandemic in PCOS women with insulin resistance (IR). Luteinizing hormone and insulin increase the risk of SARS-CoV-2 infection in these patients via induction of steroidogenic enzymes expression through cAMP-response element binding protein and Forkhead box protein O1 (FOXO1), respectively. TMPRSS2 expression is activated through phosphorylation of FOXO1 in ovaries. In other words, SARS-CoV-2 infection is associated with temporary IR by affecting ACE2 and disturbing β-pancreatic function. Therefore, PCOS, IR, and SARS-CoV-2 infection are three corners of the triangle that have complicated relations, and their association might increase the risk of SARS-CoV-2 infection and severity.
 
Keywords: Androgens, Covid 19, SARS-CoV-2, PCOS, Insulin resistance, TMPRSS2
     
Type of Study: Review | Subject: Infectious disease (Molecular and Cellular aspects)
Received: 2022/04/5 | Accepted: 2022/11/9 | Published: 2022/11/9
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Roozbeh J, Janfeshan S, Afshari A, Doostkam A, Yaghobi R. Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovaries Syndrome: A Prominent COVID-19 Risk Factor. Int J Mol Cell Med 2022; 11 (2)
URL: http://ijmcmed.org/article-1-1901-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 2 (Int J Mol Cell Med (In Press) 2022) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4514